Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density
Condition(s):Low Bone Mineral Density; Postmenopausal OsteoporosisLast Updated:September 22, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Low Bone Mineral Density; Postmenopausal OsteoporosisLast Updated:September 22, 2022Completed
Condition(s):Osteoporosis, With or Without Treatment; Bisphosphonate Treatment; Atypical Femur Fracture; Bisphosphonate Related Osteonecrosis of the Jaws (BRONJ); Healthy VolunteersLast Updated:January 13, 2023Completed
Condition(s):Cardiorenal Syndrome; Chronic Allograft NephropathyLast Updated:June 9, 2015Completed
Condition(s):OsteoporosisLast Updated:April 25, 2023Completed
Condition(s):OsteoporosisLast Updated:October 19, 2016Unknown status
Condition(s):OsteonecrosisLast Updated:January 4, 2013Completed
Condition(s):OsteoporosisLast Updated:June 26, 2018Completed
Condition(s):Osteoporosis; Atypical Femoral Fractures; Prodromal Bone DeteriorationLast Updated:March 29, 2019Completed
Condition(s):Prostate Cancer MetastaticLast Updated:June 30, 2016Terminated
Condition(s):Hip Fractures; PneumoniaLast Updated:February 20, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.